Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022.  

A discussion paper summarizing the Advisory Panel’s interim recommendations and proposed process will be posted on the CADTH website and CADTH will host an information session on January 18, 2022 at 1 p.m. (ET).  

Please see the CADTH website for more information and to register for the Information Session.

Please contact John-Paul Dowson (JP.Dowson@pdci.ca), Director of Strategic Consulting & Policy Research with any questions.